CryoLife (CRY) Tops Q1 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
CryoLife (CRY) PT Raised to $35 at Oppenheimer
April 30, 2021 6:10 AM EDTOppenheimer analyst Suraj Kalia raised the price target on CryoLife (NYSE: CRY) to $35.00 (from $29.00) while maintaining a Outperform rating.
The analyst commented, "CryoLife's 1Q21 revenues of $71.1M handily beat our/consensus estimates of $61.7M/$63.0M, up 7% y/y, bucking mid-February guide of... More
